NO20004261L - 2-aryletyl-(piperidin-4-ylmetyl)aminderivater som muscarin- reseptor antagonister - Google Patents
2-aryletyl-(piperidin-4-ylmetyl)aminderivater som muscarin- reseptor antagonisterInfo
- Publication number
- NO20004261L NO20004261L NO20004261A NO20004261A NO20004261L NO 20004261 L NO20004261 L NO 20004261L NO 20004261 A NO20004261 A NO 20004261A NO 20004261 A NO20004261 A NO 20004261A NO 20004261 L NO20004261 L NO 20004261L
- Authority
- NO
- Norway
- Prior art keywords
- arylethyl
- piperidin
- ylmethyl
- receptor antagonists
- muscarinic receptor
- Prior art date
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
- 150000001412 amines Chemical class 0.000 title 1
- -1 piperidin-4-ylmethyl Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/08—Mydriatics or cycloplegics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7611398P | 1998-02-27 | 1998-02-27 | |
| US10909798P | 1998-11-19 | 1998-11-19 | |
| PCT/EP1999/001102 WO1999043657A1 (en) | 1998-02-27 | 1999-02-19 | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20004261L true NO20004261L (no) | 2000-08-25 |
| NO20004261D0 NO20004261D0 (no) | 2000-08-25 |
| NO317106B1 NO317106B1 (no) | 2004-08-09 |
Family
ID=26757679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004261A NO317106B1 (no) | 1998-02-27 | 2000-08-25 | 2-aryletyl-(piperidin-4-ylmetyl)aminderivater som muscarin-reseptor antagonister |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6319920B1 (no) |
| EP (1) | EP1058680B1 (no) |
| JP (1) | JP3523198B2 (no) |
| KR (1) | KR100384906B1 (no) |
| CN (1) | CN1143848C (no) |
| AR (1) | AR015523A1 (no) |
| AT (1) | ATE400554T1 (no) |
| AU (1) | AU753255B2 (no) |
| BR (1) | BR9909253A (no) |
| CA (1) | CA2321198C (no) |
| CO (1) | CO4990939A1 (no) |
| DE (1) | DE69939053D1 (no) |
| ES (1) | ES2310032T3 (no) |
| HR (1) | HRP20000544A2 (no) |
| HU (1) | HUP0100760A3 (no) |
| IL (1) | IL137936A0 (no) |
| MA (1) | MA26610A1 (no) |
| MY (1) | MY133445A (no) |
| NO (1) | NO317106B1 (no) |
| NZ (1) | NZ506317A (no) |
| PE (1) | PE20000325A1 (no) |
| PL (1) | PL194037B1 (no) |
| RU (1) | RU2220138C2 (no) |
| TR (1) | TR200002481T2 (no) |
| WO (1) | WO1999043657A1 (no) |
| YU (1) | YU53100A (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7687998A (en) * | 1997-05-19 | 1998-12-11 | Sugen, Inc. | Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders |
| HUP0302015A2 (hu) | 2000-05-25 | 2003-10-28 | F. Hoffmann-La Roche Ag. | Helyettesített 1-aminoalkil-laktámok és felhasználásuk muszkarin receptor antagonistaként |
| EP1289965B1 (en) * | 2000-05-25 | 2005-10-26 | F. Hoffmann-La Roche Ag | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| EP1453806B1 (en) | 2001-12-03 | 2007-12-19 | F. Hoffmann-La Roche Ag | Aminotetralin derivatives as muscarinic receptor antagonist |
| PL370765A1 (en) * | 2001-12-03 | 2005-05-30 | F.Hoffmann-La Roche Ag | 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| CA2487899A1 (en) * | 2002-06-07 | 2003-12-18 | Yamanouchi Pharmaceutical Co., Ltd. | Overactive bladder treating drug |
| NZ537584A (en) | 2002-07-08 | 2006-07-28 | Ranbaxy Lab Ltd | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| TW200800953A (en) * | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
| CN100364990C (zh) * | 2002-10-30 | 2008-01-30 | 施万制药 | 取代的4-氨基-1-(吡啶甲基)哌啶和相关化合物 |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| DE60315258T2 (de) * | 2002-12-20 | 2008-05-08 | Dynogen Pharmaceuticals Inc., Waltham | Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals |
| EP1492519B1 (en) * | 2003-03-21 | 2006-11-15 | Dynogen Pharmaceuticals, Inc. | Methods for treating lower urinary tract disorders using antimuscarinics and alpha-2-delta subunit calcium channel modulators |
| WO2004089898A1 (en) | 2003-04-09 | 2004-10-21 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| BRPI0409302A (pt) | 2003-04-11 | 2006-04-11 | Ranbaxy Lab Ltd | derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos |
| JP2007524641A (ja) * | 2003-07-11 | 2007-08-30 | セラヴァンス， インコーポレーテッド | 置換４−アミノ−１−ベンジルピペリジン化合物 |
| FR2861073B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| US7214439B2 (en) * | 2003-12-19 | 2007-05-08 | Millennium Cell, Inc. | Triborohydride salts as hydrogen storage materials and preparation thereof |
| WO2008133900A1 (en) | 2007-04-24 | 2008-11-06 | Theravance, Inc. | Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| DE102007020492A1 (de) * | 2007-04-30 | 2008-11-06 | Grünenthal GmbH | Substituierte Sulfonamid-Derivate |
| EP3170807B1 (en) * | 2015-11-23 | 2019-12-11 | Frau Pharma S.r.l. | New method for synthesis of fenfluramine |
| SI25272A (sl) | 2016-09-23 | 2018-03-30 | Univerza V Ljubljani | Disubstituirani azetidini, pirolidini, piperidini in azepani kot zaviralci monoamin oksidaze B za zdravljenje nevrodegenerativnih bolezni |
| CN112824378A (zh) * | 2019-11-20 | 2021-05-21 | 珠海润都制药股份有限公司 | 一种盐酸坦索罗辛的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0361791B1 (en) | 1988-09-26 | 1995-11-08 | Smithkline Beecham Farmaceutici S.p.A. | Azacyclic derivatives useful as medicaments |
| SU1829346A1 (ru) * | 1991-04-01 | 1996-01-10 | Институт Тонкой Органической Химии Им.А.Л.Мнджояна | ДИГИДРОХЛОРИДЫ N-[β-(1,2,5-ТРИМЕТИЛ-4-АРИЛПИПЕРИДИН-4-ИЛ)ЭТИЛ]-N-АЛКИЛ-N-(3,4-ДИМЕТОКСИБЕНЗИЛ)АМИНОВ, ЯВЛЯЮЩИЕСЯ ИНГИБИТОРАМИ КАЛЬЦИЙ-КАЛЬМОДУЛИНЗАВИСИМЫХ ПРОЦЕССОВ |
| MY110227A (en) | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
| FR2681320B1 (fr) | 1991-09-12 | 1994-01-14 | Synthelabo | Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique. |
| FR2681325B1 (fr) | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
| ATE256110T1 (de) | 1995-09-15 | 2003-12-15 | Neurosearch As | Piperindinverbindungen als calcium-kanal-blocker |
| DE69615214T2 (de) * | 1995-10-13 | 2002-06-27 | Banyu Pharmaceutical Co., Ltd. | Substituierte heteroaromatische derivate |
-
1999
- 1999-02-01 US US09/241,816 patent/US6319920B1/en not_active Expired - Fee Related
- 1999-02-19 WO PCT/EP1999/001102 patent/WO1999043657A1/en not_active Ceased
- 1999-02-19 TR TR2000/02481T patent/TR200002481T2/xx unknown
- 1999-02-19 CN CNB998045322A patent/CN1143848C/zh not_active Expired - Fee Related
- 1999-02-19 RU RU2000124676/04A patent/RU2220138C2/ru not_active IP Right Cessation
- 1999-02-19 AU AU28353/99A patent/AU753255B2/en not_active Ceased
- 1999-02-19 CA CA002321198A patent/CA2321198C/en not_active Expired - Fee Related
- 1999-02-19 HR HR20000544A patent/HRP20000544A2/hr not_active Application Discontinuation
- 1999-02-19 EP EP99908933A patent/EP1058680B1/en not_active Expired - Lifetime
- 1999-02-19 YU YU53100A patent/YU53100A/sh unknown
- 1999-02-19 IL IL13793699A patent/IL137936A0/xx unknown
- 1999-02-19 KR KR10-2000-7009431A patent/KR100384906B1/ko not_active Expired - Fee Related
- 1999-02-19 JP JP2000533415A patent/JP3523198B2/ja not_active Expired - Fee Related
- 1999-02-19 ES ES99908933T patent/ES2310032T3/es not_active Expired - Lifetime
- 1999-02-19 PL PL99342692A patent/PL194037B1/pl unknown
- 1999-02-19 HU HU0100760A patent/HUP0100760A3/hu unknown
- 1999-02-19 BR BR9909253-0A patent/BR9909253A/pt not_active Application Discontinuation
- 1999-02-19 NZ NZ506317A patent/NZ506317A/en unknown
- 1999-02-19 DE DE69939053T patent/DE69939053D1/de not_active Expired - Lifetime
- 1999-02-19 AT AT99908933T patent/ATE400554T1/de not_active IP Right Cessation
- 1999-02-23 PE PE1999000155A patent/PE20000325A1/es not_active Application Discontinuation
- 1999-02-24 AR ARP990100772A patent/AR015523A1/es not_active Application Discontinuation
- 1999-02-24 CO CO99011501A patent/CO4990939A1/es unknown
- 1999-02-25 MY MYPI99000700A patent/MY133445A/en unknown
- 1999-02-25 MA MA25473A patent/MA26610A1/fr unknown
-
2000
- 2000-08-25 NO NO20004261A patent/NO317106B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004261D0 (no) | 2-aryletyl-(piperidin-4-ylmetyl)aminderivater som muscarin- reseptor antagonister | |
| NO20021450D0 (no) | Cykliske aminforbindelser som CCR5 antagonister | |
| NO20015365D0 (no) | Piperidinderivater som er anvendbare som CCR5-antagonister | |
| NO20012948L (no) | Hydroksydifenylureasulfonamider som IL-8 reseptor antagonister | |
| CY2010003I1 (el) | Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων | |
| DK1309559T3 (da) | 4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister | |
| DE69921351D1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
| NO20015366D0 (no) | Piperazinderivater som er anvendbare som CCR5-antagonister | |
| NO20025640L (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptorantagonister | |
| DK1305319T3 (da) | 4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister | |
| DK1068202T3 (da) | 1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister | |
| NO20004503L (no) | Vitronectin-reseptor-antagonister | |
| NO20002036L (no) | Cyklopentenderivater anvendbare som antagonister for motilinreseptoren | |
| ATE286022T1 (de) | Naphthalin-carboxamide als tachykinin rezeptorantagonisten | |
| NO20021251D0 (no) | Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister | |
| DE50008020D1 (de) | Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten | |
| NO20004144D0 (no) | Heterocykliske forbindelser, deres fremstilling og anvendelse som takykinin reseptor antagonister | |
| ATE196766T1 (de) | Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten | |
| DE60214408D1 (de) | 5-METHOXY-8-ARYL-i1,2,4öTRIAZOLOi1,5-AöPYRIDINE DERIVATIVE ALS ADENOSIN-REZEPTOR ANTAGONISTEN | |
| NO985972D0 (no) | Indolinderivater anvendelige som 5-HT-2C reseptorantagonister | |
| NO993812D0 (no) | (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler | |
| NO20010620D0 (no) | Vitronektinreseptor-antagonister | |
| NO20000518D0 (no) | 2-acylaminopropanaminer sok takykinin-reseptor-antagonister | |
| ID25461A (id) | Turunan 2-ariletil-(piperidin-4-ilmetil)amina sebagai antagonis reseptor muskarinik | |
| DK1289955T3 (da) | Piperidiner til anvendelse som orexinreceptorantagonister |